Corner Properties is a New Haven based, privately owned real estate investment company for real estate development and management. The company includes acquisition/development of biotech, flex, industrial, office, and mixed use properties. Noted for a high level of service to tenants, and identifying under-utilized assets, the company focuses on redevelopment and repositioning facilities to maximize their potential.

Whiting-Turner provides construction management, general contracting, design-build and integrated project delivery services on projects small and large for a diverse group of customers. Successful markets include office and headquarters, healthcare, senior living, science + technology, microelectronics, mission critical, retail, higher education, K-12, industrial, warehouse and distribution, transportation, multi-family residential, mixed-use, urban redevelopment, hospitality, entertainment, cultural, religious and public sector.

Since 1909, the firm has been guided by the principles of integrity, excellence and an unwavering dedication to customer delight. With headquarters in Baltimore and 60 locations across the country, Whiting-Turner is currently ranked third in domestic building construction by Engineering News-Record. The firm’s over 4,600 salaried professionals provide depth of resources to service nationally and to build locally.

The strength and stability of the firm is well documented. Whiting-Turner enjoys a 5A-1 Dun & Bradstreet rating – the only domestic builder with this highest rating – and a bonding capacity of $4 billion. The firm is financially independent, having not borrowed money since 1938.

For details on Whiting-Turner’s expertise building science and technology facilities, click here.

i2e Consulting leads the digital transformation for the life sciences industry through best-in-class innovative technology solutions. Our market leading execution capabilities and domain expertise help pharmaceutical companies, biotech, and healthcare organizations deliver innovations that create a healthier world.

We help R&D, clinical development, commercialization functions accelerate time-to-value, prioritize industry leading innovation, and establish portfolio leadership.

Ethnic Online Foundation is a 501C3 dedicated to “building the next Generation of Black & Brown STEM Professionals” through our program offerings:

– Supporting STEM Summer Camps

– STEM 101 for Parents Outreach Program

– STEM Scholarships for High School Students

HighCape Capital is a growth equity firm that finances and assists innovative life sciences companies as they transition from the initial stages of their business cycle into successful, thriving organizations.

Control Associates is a provider of control systems, valves, instrumentation, pressure management, asset reliability, MES, PAT, systems integration and data management solutions to industrial and commercial customers in the tri-state metropolitan New York, New Jersey and Connecticut region. Our unique long-term partnership with Emerson and other leading manufacturers, enables us to connect customers with innovative technology, technical expertise and 24/7 lifecycle support services to optimize the reliability, safety, performance and profitability of their operations.

In August of 2018, Emerson certified Control Associates as an Emerson Impact Partner representing the company’s highest level of customer support. Control Associates and the Emerson Impact Partner Network companies across North America operate as locally-accessible, singular points of contact for leveraging the full breadth of Emerson integrated solutions and expertise.

Founded in 1990, OR&L Commercial Real Estate provides complete real estate services including Selling and Leasing of Commercial Real Estate locally, nationally, and internationally. The company specializes in representing major industrial and office property owners, investors, tenant / buyer representation for corporations and not for profit organizations, new construction development, built to suit medical requirements and turn-key laboratory space development for Bio-Science companies.

Unique to O,R&L is the alliance between its four divisions – Brokerage, Construction, Property Management and Maintenance. These integrated business services work together to analyze their clients’ business needs, identify appropriate alternatives, examine the cost of retro-fit or new construction, and create an on-going budget to maximize efficiency while minimizing operating expenses. Each division is supervised by one of the four partners in his area of expertise. The partners have a successful background in advising investors, corporations, and public institutions on the complex issues affecting business owners and managers.

E3 Science Partners Inc is a nimble, deeply experienced consultancy dedicated to providing scalable scientific communications and medical affairs services at competitive costs.  Our three Founding Partners formerly comprised the leadership team of BioScience Communications, the medical and regulatory communications division of Edelman, the world’s largest public relations firm. We started E3 Science Partners to focus our expertise in strategy, science writing, and expert engagement on behalf of early and clinical stage companies and to enhance their outreach to the scientific community, investors, regulators, and third-party groups.

Depending on your specific situation and needs, we can provide full-scale fractional medical affairs or support your existing functions with our proven strategies and skills. We specialize in establishing the communications infrastructure for emerging products and portfolios, starting with scientific messaging and narrative and building from there to strategic publication planning and thought leader engagement via advisory boards, congresses, and digital and social media.

Curatix LLC focuses on the development of new antimicrobial therapies and therapeutic strategies with a specific focus on antifungal and anti-parasitic drugs and diagnostic tests.

Research Activities:

– Examine the antifungal activity of ELV compounds against various fungal pathogens in vitro and in mice

– Determine the in vitro and in vivo safety profiles of the lead compounds

– Continue optimization of the lead compounds

– Identify novel PAMS as potentiators of antifungal susceptibility.

Virtus Therapeutics (C-corp) is focused on the development of the first treatment for pantothenate kinase-associated neurodegeneration (PKAN) using small molecule activators.

Research Activities:

– Evaluate the activity of VTACs in cell-based assays

– Select advanced derivatives of VTACs using biochemical, structural and cell biological assays.

– Evaluate the activity of VTACs in animal models of PKAN